Global Point-of-Care/Rapid Diagnostics Market Development and Demand Forecast to 2022
The global point-of-care diagnostics market is estimated to be valued at USD 23.71 billion in 2017 and is projected to reach USD 38.13 billion by 2022 growing at a CAGR of 10.0%. Increasing private investments and venture funding towards the development of new products along with the growing government support to increase the adoption of POC devices are expected to drive the demand for point-of-care...
Flow Cytometry Market – Analysis, Scope And Forecast 2017 – 2022
The flow cytometry market is projected to register a CAGR of 7.8% from USD 3.29 billion in 2017 to USD 4.79 billion in 2022. Growth in flow cytometry market can be attributed to factors such as the continuous technological advancements in the field of flow cytometry, increasing incidence and prevalence of target diseases (such as HIV/AIDS and cancer), growing adoption of flow cytometry in advanced...
RSV Diagnostics Market by Key Players and Trends
The RSV diagnostics market is expected to reach USD 929.2 million by 2022 from USD 574.3 million in 2017, at a CAGR of 10.1%. Factors driving the growth of this market include the rising burden of RSV infections, growing demand for PoC molecular diagnostic tests for the diagnosis of RSV infections, and increasing approval of RSV diagnostic kits and assays.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=95683942
The...
Creatinine Assay Kits Market – Trends, Business Strategies and Opportunities 2022
The global creatinine assay kits market is expected to reach USD 245.4 million by 2022 from USD 189.6 million in 2017, at a CAGR of 5.3%. This market is experiencing significant growth due to increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government...
Leading players and Trends of “Immunofluorescence Assay market”
The global immunofluorescence assay market is projected to reach USD 2.01 billion by 2023 from USD 1.51 billion in 2018, at a CAGR of 5.8%. The increasing prevalence of chronic diseases, increasing R&D spending and increasing healthcare spending are the major factors driving the growth of the immunofluorescence assay market. High growth opportunities in emerging markets provide opportunities for...
The Exciting World of Biomarkers
From being physiological indicators such as body temperature, blood pressure and heart rates, Biomarkers or biological markers have now come a long way! They have evolved to be excellent tools in the hand of a biologist driving innovation, improving efficiency of processes, saving costs and actually helping critical decisions in the drug discovery and clinical medicine arena. In recent years, they...